Physician profile
James Joseph Fox
NPI 1598775918
$2,622.05
in general payments reported to CMS, 2019-2025
17 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $79.41 · 2021: $189 · 2022: $647 · 2023: $672 · 2024: $387 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,217.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $803.69 | 2019-2024 | Xarelto |
| Amgen INC. | $791.86 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $174.96 | 2019-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $172.62 | 2023-2024 | |
| Kestra Medical Technology Services, INC. | $126.56 | 2022-2023 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $123.00 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $86.48 | 2021-2023 | Verquvo |
| Boston Scientific Corporation | $68.66 | 2019-2023 | Watchman Access System |
| Cvrx, INC. | $64.76 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.97 | 2019-2023 | Jardiance |
| Philips North America LLC | $33.65 | 2022-2024 | (Ck7) Extended Holter |
| Baxter Healthcare | $24.79 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Impulse Dynamics (USA) INC. | $23.66 | 2023 | Optimizer |
| Infobionic, INC | $21.33 | 2024 | Mome Device |
| Agepha Pharma Fz LLC | $19.89 | 2025 | Lodoco |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.37 | 2023 | |
| G Medical Diagnostic Services, INC. | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.